CTOs on the Move

Nashville General Hospital at Meharry

www.nashvilleha.org

 
Nashville General Hospital at Meharry is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Nashville General Hospital at Meharry is based in Nashville, TN. You can find more information on Nashville General Hospital at Meharry at www.nashvilleha.org
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.

Omnibus Health

Omnibus Health is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Protectus Medical Devices

Protectus Medical Devices is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Patient Interaction

Patient Interaction is a Bronx, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthReveal

HealthReveal is a clinical AI company dedicated to improving outcomes and quality of life for patients with chronic disease by enabling clinicians to deliver the most effective evidence-based treatments tailored to each patient’s unique circumstances, every time. By using machine learning and bridging each patient’s information with the latest medical guidelines, we predict individual patient health risks and disease progression and prescribe individual treatment interventions to mitigate risks, improve quality and reduce costs.